for the Period Ended 30 November 2025
| Directors report | |
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 November 2025
Principal activities of the company
Political and charitable donations
Company policy on disabled employees
Additional information
Review of business and future developments The financial position at 30 November 2025 is inline with expectations. Opportunities for developing the global position of Seal laboratory equipment continue to be explored. Further discussion of the business review and future developments, in the context of the Porvair group as a whole, including the Company, is provided in the Chairman’s statement, Chief Executive’s report and the Finance Director’s review in the Porvair plc 2025 annual report and financial statements, which does not form part of this report. Research and development The Company continues a programme of development of its existing systems and new systems to support future growth opportunities. The development is largely completed in-house rather than through third parties. Key performance indicators The Company considers its key performance indicators to be revenue growth, operating margin and profit before tax growth, measured against prior year. Further discussion of these key performance indicators, in the context of the group as a whole, including the Company, is provided in the Chairman’s statement, Chief Executive’s report and the Finance Director’s review in the Porvair plc 2025 annual report and financial statements, which does not form part of this report. Financial risk management The Company’s operations expose it to a variety of financial risks that include the effects of liquidity risk, foreign exchange risk and credit risk. The Company has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the Company. Given the size of the Company, the Directors have not delegated the responsibility of monitoring financial risk management to a sub-committee of the board. The policies set by the board of Directors are implemented by the Company’s finance department. Liquidity risk The ultimate parent company ensures the Company has sufficient available funds for operations and planned growth. Foreign exchange risk The Company sells its products in both US dollars and Euros and is exposed to exchange rate movements. The exposure to exchange rate movements is partially mitigated by purchases in those currencies and intercompany loan balances, in addition to which the Company selectively enters into forward currency contracts via its parent company in relation to its principal foreign currency denominated revenues to reduce the impact of exchange rate movements. Credit risk The Company has implemented policies that require appropriate credit checks on potential customers before sales are made. The amount of exposure to any individual counterparty is subject to a limit, which is reassessed annually. Results and dividends The Company made a profit after tax for the financial year of £273,000 (2024: £16,000). The Company paid £350,000 dividend in the year (2024: £nil). The Directors do not recommend any further payment of a dividend. Going concern The Directors have made appropriate enquiries and reviewed the current financial position, including all the information presented in its strategic review of the business and the forecast covering the twelve months from the date of this report (“the going concern assessment period”) and have considered foreseeable downsides, stress tests and scenarios. The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the going concern assessment period. As at 30 November 2025 the Company had £131,000 (2024: £428,000) in cash and cash equivalents. The Company is currently forecasting to be profitable and cash positive for the 12 months from the date of this report and the foreseeable future, being a period of no less than 12 months from the date of signing of the financial statements. The Company has the full financial support, from its ultimate parent, Porvair plc, and the Directors are confident the Company’s group will continue to have sufficient resources to provide support if required. Further detail is contained in the viability statement and going concern disclosure included in the Strategic report of Porvair plc’s financial statements. The Company therefore continues to adopt the going concern basis in preparing its financial statements.
Directors
The directors shown below have held office during the whole of the period from
1 December 2024
to
30 November 2025
The director shown below has held office during the period of
1 December 2024
to
15 April 2025
Secretary
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Secretary
for the Period Ended
| 2025 | 2024 | |
|---|---|---|
|
|
£ |
£ |
| Turnover: |
|
|
| Cost of sales: |
(
|
(
|
| Gross profit(or loss): |
|
|
| Distribution costs: |
(
|
(
|
| Administrative expenses: |
(
|
(
|
| Operating profit(or loss): |
|
|
| Profit(or loss) before tax: |
|
|
| Tax: |
(
|
|
| Profit(or loss) for the financial year: |
|
|
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Intangible assets: | 3 |
|
|
| Investments: | 4 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: | 5 |
|
|
| Debtors: | 6 |
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 7 |
(
|
(
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Share premium account: |
|
|
|
| Profit and loss account: |
|
|
|
| Total Shareholders' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2025
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Intangible fixed assets amortisation policy
Other accounting policies
for the Period Ended 30 November 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 November 2025
| Goodwill | Other | Total | |
|---|---|---|---|
| Cost | £ | £ | £ |
| At 1 December 2024 |
|
|
|
| Additions | |||
| Disposals | |||
| Revaluations | |||
| Transfers | |||
| At 30 November 2025 |
|
|
|
| Amortisation | |||
| At 1 December 2024 |
|
|
|
| Charge for year | |||
| On disposals | |||
| Other adjustments | |||
| At 30 November 2025 |
|
|
|
| Net book value | |||
| At 30 November 2025 |
|
|
|
| At 30 November 2024 |
|
|
|
for the Period Ended 30 November 2025
For the year ended 30 November 2025, there was no impairment of the investments and as at 30 November 2025 no further payments are due to be paid. Pulse Instrumentation GmbH Sale of water analysis consumables Germany 100% Rohasys B.V. Manufacture and sale of robotic sample handling systems Netherlands 100% Seal Analytical GmbH Manufacture and sale of water analysis equipment and related consumables Germany 100%
for the Period Ended 30 November 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Stocks |
|
|
| Total |
|
|
for the Period Ended 30 November 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Trade debtors |
|
|
| Other debtors |
|
|
| Total |
|
|
for the Period Ended 30 November 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Trade creditors |
|
|
| Taxation and social security |
|
|
| Accruals and deferred income |
|
|
| Other creditors |
|
|
| Total |
|
|